Bio-Connect
FACS analysis of human PBMC stimulated overnight with PMA and Ionomycin stained APC anti-human CD4 antibody, followed by intracellular staining with GTX00492-08 CTLA4 antibody [BNI3] (PE). Right panel : Co-stained with APC anti-human CD4 antibody and GTX00492-08 Left panel : Co-stained with APC anti-human CD4 antibody and PE mouse IgG2a isotype control Antibody amount : 0.5 microg
FACS analysis of human PBMC stimulated overnight with PMA and Ionomycin stained APC anti-human CD4 antibody, followed by intracellular staining with GTX00492-08 CTLA4 antibody [BNI3] (PE). Right panel : Co-stained with APC anti-human CD4 antibody and GTX00492-08 Left panel : Co-stained with APC anti-human CD4 antibody and PE mouse IgG2a isotype control Antibody amount : 0.5 microg
FACS analysis of human PBMC stimulated overnight with PMA and Ionomycin stained APC anti-human CD4 antibody, followed by intracellular staining with GTX00492-08 CTLA4 antibody [BNI3] (PE). Right panel : Co-stained with APC anti-human CD4 antibody and GTX00492-08 Left panel : Co-stained with APC anti-human CD4 antibody and PE mouse IgG2a isotype control Antibody amount : 0.5 microg

CTLA4 antibody [BNI3] (PE)

Research Use Only
GTX00492-08
GeneTex
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman, Monkey, Primate
TargetCTLA4
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CTLA4 antibody [BNI3] (PE)
  • Delivery Days Customer
    9
  • Application Supplier Note
    FACS: 0.5 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    BNI3
  • Concentration
    0.1 mg/ml
  • Conjugate
    RPE
  • Formulation
    Liquid
  • Gene ID1493
  • Target name
    CTLA4
  • Target description
    cytotoxic T-lymphocyte associated protein 4
  • Target synonyms
    ALPS5; CD; CD152; celiac disease 3; CELIAC3; CTLA-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; cytotoxic T-lymphocyte protein 4; cytotoxic T-lymphocyte-associated serine esterase-4; GRD4; GSE; IDDM12; insulin-dependent diabetes mellitus 12; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDP16410
  • Protein Name
    Cytotoxic T-lymphocyte protein 4
  • Scientific Description
    This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human, Monkey, Primate
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4). Zhao Y et al., 2017 Jun, Biomed Pharmacother
    Read more
  • Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. Miles B et al., 2016 Oct, PLoS Pathog
    Read more
  • Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sezary syndrome. Gibson HM et al., 2013 Jan, J Invest Dermatol
    Read more
  • Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Moreno-Fernandez ME et al., 2011 May 19, Blood
    Read more
  • CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. Green AM et al., 2010 Aug 15, J Infect Dis
    Read more
  • An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. Schoenfeld D et al., 2009 May 19, Proc Natl Acad Sci U S A
    Read more
  • Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Bonzheim I et al., 2008 Oct, Am J Clin Pathol
    Read more
  • The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Young NT et al., 2008 Mar 15, Blood
    Read more
  • Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. Jonuleit H et al., 2001 Jun 4, J Exp Med
    Read more
  • Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. Oaks MK et al., 2000 May 15, J Immunol
    Read more